- Home
- GOSS vs SHBI Comparison
GOSS vs SHBI Comparison
Compare GOSS & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- SHBI
- Stock Information
- Founded
- GOSS 2015
- SHBI 1876
- Country
- GOSS United States
- SHBI United States
- Employees
- GOSS N/A
- SHBI N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- SHBI Major Banks
- Sector
- GOSS Health Care
- SHBI Finance
- Exchange
- GOSS Nasdaq
- SHBI Nasdaq
- Market Cap
- GOSS 501.2M
- SHBI 548.4M
- IPO Year
- GOSS 2019
- SHBI N/A
- Fundamental
- Price
- GOSS $2.37
- SHBI $16.20
- Analyst Decision
- GOSS Strong Buy
- SHBI Buy
- Analyst Count
- GOSS 6
- SHBI 1
- Target Price
- GOSS $8.60
- SHBI $20.00
- AVG Volume (30 Days)
- GOSS 3.0M
- SHBI 135.7K
- Earning Date
- GOSS 11-05-2025
- SHBI 10-23-2025
- Dividend Yield
- GOSS N/A
- SHBI 3.04%
- EPS Growth
- GOSS N/A
- SHBI 38.19
- EPS
- GOSS N/A
- SHBI 1.71
- Revenue
- GOSS $40,237,000.00
- SHBI $212,493,000.00
- Revenue This Year
- GOSS N/A
- SHBI N/A
- Revenue Next Year
- GOSS $16.11
- SHBI $6.89
- P/E Ratio
- GOSS N/A
- SHBI $9.50
- Revenue Growth
- GOSS N/A
- SHBI 10.07
- 52 Week Low
- GOSS $0.66
- SHBI $11.47
- 52 Week High
- GOSS $3.60
- SHBI $17.67
- Technical
- Relative Strength Index (RSI)
- GOSS 48.07
- SHBI 54.40
- Support Level
- GOSS $2.28
- SHBI $15.45
- Resistance Level
- GOSS $2.52
- SHBI $16.10
- Average True Range (ATR)
- GOSS 0.15
- SHBI 0.43
- MACD
- GOSS 0.02
- SHBI 0.06
- Stochastic Oscillator
- GOSS 62.79
- SHBI 89.47
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.